Skip to content

HeartWare™ Battery 1650

by Heartware Inc. EUDAMEDGUDID

Active European Union and United States

Ref 1650

Regulatory status

as of 28 Oct 2026

Recall ongoing. 51 ongoing FDA recalls. See recalls

RegionAuthorizationNumberDateStatus
European UnionCE/MDR EUDAMED NumberMDR 737528 Date28 Jul 2026IssuedStatusActive expires 28 Aug 2029
United StatesGUDID listing GUDID Number00763000923655 UDI-DIDate1 May 2026ListedStatusIn distribution

Coverage

2 jurisdictions

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaSwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered
  • European Union CE/MDR Active
  • United States GUDID listing Listed

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • MDR 737528 Supplemented

    Technical documentation EU MDR

    Notified body
    Notified body 2797
    Issued
    28 Jul 2026
    Expires
    28 Aug 2029
    Reason
    Change approved

Recalls

60 recalls · 51 ongoing · FDA

    • Ongoing Z-0475-2024 FDA Class II initiated 31 Oct 2023

    Updates to the HVAD system instructions for use (IFU) and patient manual (PM) will be provided. These updates will clarify (1) the conditions under which an HVAD [Controller Fault] alarm may sound and the recommended troubleshooting actions and (2) instructions relating to the useful life of the HVAD system components

    • Ongoing Z-1993-2023 FDA Class II initiated 16 May 2023

    Medtronic has identified that the logfiles downloaded from the recently updated Model 1521 monitors (Serial Numbers: MON4xxxxxx for OUS and MON5xxxxxx for US), are unable to be processed by the Autologs web portal.

    • Ongoing Z-1512-2022 FDA Class I initiated 28 Jun 2022

    Battery performance issues. Battery electrical faults render it unable to power the controller, unable to accept charge from the battery charger, and/or result in the battery to appear to remain charged while discharging.

    • Ongoing Z-1266-2022 FDA Class I initiated 5 May 2022

    Batteries for the HVAD system have a weld defect affecting internal components within the HVAD battery, resulting in the battery to malfunction and no longer provide power or prevent the battery from holding a complete charge or properly recharging.

    • Ongoing Z-1207-2022 FDA Class I initiated 14 Apr 2022

    The pump may have a welding defect that can lead the pump to malfunction. The issue is under investigation by the firm. It is suspected that a weld defect on the center post cap may allow moisture into the center post and corrode the magnets that keep the impeller rotating concentrically, leading to unintended contact between the center post and impeller. If this occurs, it may affect blood flow through the pump. The issue may present clinical signs and symptoms that resemble pump thrombosis.

  • 6 recalls, same reason

    • Ongoing Z-1105-2022 FDA Class II initiated 30 Mar 2022
    • Ongoing Z-1106-2022 FDA Class II initiated 30 Mar 2022
    • Ongoing Z-1104-2022 FDA Class II initiated 30 Mar 2022
    • Ongoing Z-1107-2022 FDA Class II initiated 30 Mar 2022
    • Ongoing Z-1102-2022 FDA Class II initiated 30 Mar 2022
    • Ongoing Z-1103-2022 FDA Class II initiated 30 Mar 2022

    Finnish and Turkish translation errors in HVAD controller and monitor displays as will as Instructions for Use, Patient Manual, and Emergency Responder Guide for the HeartWare Ventricular Assist Device (HVAD) system.

    • Ongoing Z-1110-2022 FDA Class II initiated 30 Mar 2022

    Errors and inconsistencies that were identified in the Instruction for Use (IFU), Emergency Responder Guide (ERG), and Patient Manual (PM) for the HeartWare Ventricular Assist Device (HVAD) system.

    • Ongoing Z-0726-2022 FDA Class II initiated 27 Jan 2022

    Updated cleaning instructions are being provided for the Controller AC Adapter, DC Adapter, and Battery to provide clarity to avoid cleaning the power source connector pins, as this could remove the lubricant that is applied to the pins as a mitigation for power switching.

    • Ongoing Z-2478-2021 FDA Class II initiated 6 Aug 2021

    There is more force required to slide the driveline cover (boot cover) away from the connector after completion of a Driveline Strain Relief Repair than over an unrepaired strain relief. This may lead to difficulty in pulling back the driveline cover when attempting to access the Driveline connector during a controller exchange. Additionally, sliding the driveline cover over a strain relief repair may compromise the repair.

  • 10 recalls, same reason

    • Ongoing Z-2191-2021 FDA Class I initiated 3 Jun 2021
    • Ongoing Z-2188-2021 FDA Class I initiated 3 Jun 2021
    • Ongoing Z-2194-2021 FDA Class I initiated 3 Jun 2021
    • Ongoing Z-2193-2021 FDA Class I initiated 3 Jun 2021
    • Ongoing Z-2189-2021 FDA Class I initiated 3 Jun 2021
    • Ongoing Z-2192-2021 FDA Class I initiated 3 Jun 2021
    • Ongoing Z-2197-2021 FDA Class I initiated 3 Jun 2021
    • Ongoing Z-2190-2021 FDA Class I initiated 3 Jun 2021
    • Ongoing Z-2195-2021 FDA Class I initiated 3 Jun 2021
    • Ongoing Z-2196-2021 FDA Class I initiated 3 Jun 2021

    Medtronic is stopping the distribution and sale of the HVAD System due to a growing body of observational clinical comparisons that shows a higher frequency of neurological adverse events and mortality associated with the system when compared to other commercially available left ventricular assist devices, as well as complaints that the internal pump may delay or fail to restart.

  • 6 recalls, same reason

    • Ongoing Z-1339-2021 FDA Class I initiated 26 Feb 2021
    • Ongoing Z-1340-2021 FDA Class I initiated 26 Feb 2021
    • Ongoing Z-1341-2021 FDA Class I initiated 26 Feb 2021
    • Ongoing Z-1336-2021 FDA Class I initiated 26 Feb 2021
    • Ongoing Z-1338-2021 FDA Class I initiated 26 Feb 2021
    • Ongoing Z-1337-2021 FDA Class I initiated 26 Feb 2021

    There is the potential for the Controller power cables (AC Adapter, DC Adapter, and Battery cables), HVAD Alarm Adapter, and HVAD Monitor data cables to cause damage to the HVAD Controller ports when inserting the cables into the Controller ports, due to wear from misalignment of the cables to the port.

    • Ongoing Z-1469-2021 FDA Class II initiated 26 Feb 2021

    IFU and Patient Manual updated to describe Expected Alarm Duration. The Instructions for Use (IFU) is being updated to advise clinicians that alarms that resolve after a very short period may mean there is an intermittent problem and the cause of the alarm can be evaluated by analysis of the controller log files. The Patient Manual (PM) is being updated to instruct patients to contact their clinicians if they cannot identify an alarm before it is cleared as it might mean there is an intermittent problem. NOTE: this update is included in the February 2021 Urgent Medical Device Notice also covered in recalls 87456 and 87604

    • Ongoing Z-1438-2021 FDA Class II initiated 26 Feb 2021

    IFU and Patient Manual updated to describe HVAD Controller Connection Verification. The labeling is being corrected to reflect the actual verified behavior of a successful connector to the controller, which is a "beep" and not "audible click", to clarify under what alarm conditions a beep will not be heard, and identify alternate confirmation methods (visual indicator) for successful connection. NOTE: this update is included in the February 2021 Urgent Medical Device Notice also covered in recalls 87456 and 87603

    • Ongoing Z-1426-2021 FDA Class I initiated 26 Feb 2021

    Medtronic HeartWare HVAD System Instructions for Use (IFU) and Patient Manual (PM) updates regarding: Carrying Cases, Driveline Cover Orientation, and Controller Power Up Sequence issues. The PM is being updated to clarify use of the support strap and wear instructions in addition to cleaning instructions of the carrying cases. The IFU and PM are being updated to add a useful life for the carrying cases. The PM is being updated to inform users to keep the driveline cover on when disconnecting and reconnecting the driveline. The IFU and PM are being updated to clarify the power-up sequence that causes the alarm indicator LEDs and both sets of battery LEDs to turn red for 2.5 seconds while the LCD displays the power-on message. NOTE: this update is included in the February 2021 Urgent Medical Device Notice also covered in recalls 87603 and 87604

    • Ongoing Z-0946-2021 FDA Class I initiated 19 Nov 2020

    Pumps manufactured with impellers from a subset of lots from a single supplier are failing to initially start, restart, or experiencing a delay in restart within the maximum number of restart attempts at a rate substantially higher than pump in the overall population.

  • 5 recalls, same reason

    • Ongoing Z-2057-2020 FDA Class I initiated 3 Apr 2020
    • Ongoing Z-2055-2020 FDA Class I initiated 3 Apr 2020
    • Ongoing Z-2059-2020 FDA Class I initiated 3 Apr 2020
    • Ongoing Z-2058-2020 FDA Class I initiated 3 Apr 2020
    • Ongoing Z-2056-2020 FDA Class I initiated 3 Apr 2020

    The Outflow Graft may be subject to tears and the Strain Relief screw may break during the pre-implant pump assembly and attachment to the HVAD Pump.

  • 2 recalls, same reason

    • Ongoing Z-1427-2020 FDA Class I initiated 23 Jan 2020
    • Ongoing Z-1428-2020 FDA Class I initiated 23 Jan 2020

    Potential for an HVAD System user to mistakenly insert the Battery Charger AC Adapter into an HVAD Controller power port.

    • Ongoing Z-1903-2018 FDA Class I initiated 2 May 2018

    Possible transient electrical connection interruption between an HVAD System power source (Battery, AC Adapter, or DC Adapter) and the Controller, while the power source is connected, that may cause unintended switching to the secondary power source and/or unexpected audible tones (beeping). The interruption typically lasts 1-2 seconds, due to oxidation between power source connector and socket.

    • Ongoing Z-1832-2017 FDA Class I initiated 10 Mar 2017

    In April 2015, HeartWare, now a part of Medtronic, notified users of a safety issue related to the HVAD Pump Driveline Splice Kit. Medtronic now intends to send a follow-up communication to identified clinicians informing them that a new, improved splice kit is available.

    • Ongoing Z-1538-2017 FDA Class I initiated 3 Feb 2017

    Product recall of all HVAD Controllers currently on the market and to exchange them for the next generation HVAD Controller (Controller2.0)

    • Ongoing Z-0006-2017 FDA Class I initiated 17 Aug 2016

    Foreign material found within the driveline connector of the HVAD Pump that could cause increased impedance resulting in electrical faults.

    • Ongoing Z-1731-2015 FDA Class I initiated 29 Apr 2015

    Complaints with the HVAD Internal Controller Alarm Battery failures.

    • Ongoing Z-1604-2015 FDA Class I initiated 29 Apr 2015

    Failures of the splice repair kit if exposed to excessive force.

    • Ongoing Z-1726-2015 FDA Class I initiated 29 Apr 2015

    Complaints with the HVAD Retraction of Pins within the driveline connector.

    • Ongoing Z-1917-2015 FDA Class II initiated 29 Apr 2015

    Complaints with the HVAD Abnormal Power Source Switching.

    • Ongoing Z-1698-2015 FDA Class I initiated 29 Apr 2015

    HeartWare has received complaints relating to damage or bent connection pins within the power supply ports of the VAD controller.

    • Ongoing Z-1751-2015 FDA Class II initiated 29 Apr 2015

    Complaints with the HVAD Discolored and Cracked Driveline Outer Sheath.

    • Terminated Z-2072-2021 FDA Class II initiated 28 May 2021

    The pump has an impeller with a shroud height that did not meet the lower control limit.

    • Terminated Z-0582-2019 FDA Class II initiated 19 Nov 2018

    HVAD Battery Charger units manufactured with wrong inductors.

    • Terminated Z-0067-2019 FDA Class II initiated 28 Aug 2018

    Certain HVAD System Controller units may not meet the labeled standard for protection against water or fluid ingress, specifically they may have the potential to develop hairline cracks at the power ports of the controller housing.

    • Terminated Z-0005-2017 FDA Class I initiated 8 Jun 2016

    Loose connector ports in controller body.

    • Terminated Z-1887-2016 FDA Class I initiated 7 Jan 2016

    Heartware Ventricular Assist System Battery Cell experiencing premature depletion.

    • Terminated Z-1131-2015 FDA Class I initiated 16 Jan 2015

    The affected clinical trial Controllers exhibit a higher susceptibility to ESD than newer commercial Controllers.

    • Terminated Z-1607-2014 FDA Class II initiated 16 Apr 2014

    Patients and caregivers are instructed that if a battery does not provide two hours of support or behaves unusually, that battery should no longer be used and should be replaced.

    • Terminated Z-1471-2014 FDA Class I initiated 6 Dec 2013

    The housing to the Pump's driveline connector became partially or fully separated from the front portion of the driveline connector.

    • Terminated Z-1813-2013 FDA Class II initiated 16 May 13

    Potential to electrostatic discharged (ESD)

Specification

EUDAMED · GUDID

Trade Name
HeartWare™ Battery
Generic Name
Implantable ventricular circulatory assist system
Device Name
HeartWare HVAD System
Model / Reference
1650
Primary DI / UDI-DI
00763000923655
Basic UDI-DI
0763000B000092489
PMA Number
FDA Product Code
DSQ
EMDN Code
J01030102 Implantable left monoventricular assistance systems (lvad)
GMDN Term
Implantable ventricular circulatory assist system
Device Class
Class III
Market of Registration
Netherlands
Commercial Distribution
In Commercial Distribution
MRI Safety
MR Unsafe

Other devices from Heartware Inc.

See all devices from Heartware Inc. →

Properties

  • Implantable
  • Prescription Use
  • Serial Number

Other properties (21)

  • Sterile: No
  • Single Use: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No
  • Over-the-Counter: No
  • Convenience Kit: No
  • Combination Product: No
  • HCT/P: No
  • Premarket Exempt: No
  • Lot / Batch Number: No
  • Expiration Date: No
  • Manufacturing Date: No